Roel Bulthuis, senior vice-president and managing director at M Ventures, has moved on to Inkef Capital as head of healthcare and is succeeded by Jasper Bos at the corporate venture capital unit.
Roel Bulthuis (pictured), senior vice-president and managing director at M Ventures, the corporate venturing unit of Germany-based drugs group Merck, has joined Netherlands-based venture capital fund Inkef Capital as head of healthcare.
Bulthuis will co-manage the Inkef fund alongside Robert Jan Galema, head of the technology team. At M Ventures, he will be succeeded by Jasper Bos as new managing director and senior vice-president.
Bos said: “What excites me most about my work for M Ventures is the active role we play in…
